Predominance of CD4+T cells in metastatic cervical lymph nodes in papillary thyroid carcinoma

被引:1
作者
Moma, Camila Aparecida [1 ]
Barreto, Icleia Siqueira [2 ]
Assumpcao, Ligia Vera Montali [1 ]
Zantut-Wittmann, Denise Engelbrecht [1 ]
机构
[1] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Endocrinol Div, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Campinas, SP, Brazil
关键词
CD4+T lymphocyte; lymph node metastasis; lymphocytic subpopulation; papillary thyroid carcinoma; CHRONIC LYMPHOCYTIC THYROIDITIS; REGULATORY T-CELLS; HASHIMOTOS-THYROIDITIS; CANCER; ASSOCIATION; PROGNOSIS; TRENDS;
D O I
10.1530/EC-24-0135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Papillary thyroid carcinoma has become increasingly prevalent over the years. Avoiding unnecessary treatments and the risk of complications is essential, as well as understanding the mechanisms of tumor progression and the conditions that indicate a worse prognosis. Assessment of the tumor microenvironment can allow us understand how the immune system organizes itself to contain neoplastic progression.Methods We compared characteristics related to the lymphocytic subpopulations in the thyroid tumor microenvironment and lymph nodes in two groups, with and without lymph node metastatic involvement.Results Of the 400 cases followed up at a thyroid cancer reference service, 32 were selected, of which, 13 cases did not present lymph node metastasis (N0 group) and 19 had lymph node involvement (N1 group). Clinical data were collected, and immunohistochemical reactions were performed for markers CD4, CD8, FoxP3, CD25, and CD20 in lymph nodes and peritumoral infiltrate. We found that the N1 group had larger tumor sizes, higher risk staging, higher frequency of extrathyroidal extension, shorter disease-free times, and higher expression of CD4+ T lymphocytes in lymph nodes; however, there was no difference in the expression of other markers or in the pattern of lymphocyte distribution in the lymph node.Conclusion In cervical lymph nodes, the higher frequency of CD4+ T lymphocytes is related to the presence of metastasis. However, there were no differences in lymphocytic subpopulations in the thyroid tumor microenvironment. The absence of changes in unaffected lymph nodes could not predict any tumor behavior.
引用
收藏
页数:9
相关论文
共 34 条
[1]  
Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M., Update on fundamental mechanisms of thyroid cancer, Frontiers in Endocrinology (Lausanne), 11, (2020)
[2]  
Davies L, Hoang JK., Thyroid cancer in the USA: current trends and outstanding questions, Lancet Diabetes and Endocrinology, 9, pp. 11-12, (2021)
[3]  
Kitahara CM, Sosa JA., The changing incidence of thyroid cancer, Nature Reviews Endocrinology, 12, pp. 646-653, (2016)
[4]  
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM., Trends in thyroid cancer incidence and mortality in the United States, 1974– 2013, JAMA, 317, pp. 1338-1348, (2017)
[5]  
Cho YA, Kim J., Thyroid cancer risk and smoking status: a meta-analysis, Cancer Causes and Control, 25, pp. 1187-1195, (2014)
[6]  
Franchini F, Palatucci G, Colao A, Ungaro P, Macchia PE, Nettore IC., Obesity and thyroid cancer risk: an update, International Journal of Environmental Research and Public Health, 19, (2022)
[7]  
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Et al., American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer, Thyroid, 2016 26, pp. 1-133, (2015)
[8]  
Xing M., Molecular pathogenesis and mechanisms of thyroid cancer, Nature Reviews Cancer, 13, pp. 184-199, (2013)
[9]  
Mete O, Wenig BM., Update from the 5th edition of the world health organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms, Head and Neck Pathology, 16, pp. 123-142, (2022)
[10]  
Jeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS., Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome, Journal of Korean Medical Science, 27, pp. 883-889, (2012)